Pharmaceuticals

Impact Of Growing Preterm Births On The Market Growth Is Supporting Development Across The Pediatric Drugs Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Pediatric Drugs Market Over The Forecast Period?

The pediatric drugs market has witnessed substantial growth in recent years. This market is projected to expand from $179.43 billion in 2025 to $205.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.6%. Historically, this expansion can be ascribed to a significant incidence of pediatric infectious diseases, the broadening of vaccination and treatment initiatives, the development of pediatric hospital infrastructure, improved access to child healthcare, and a greater understanding of pediatric medication safety.

The pediatric drugs market is projected to experience substantial expansion over the upcoming years. Its value is set to reach $352.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.4%. This projected increase during the forecast period stems from factors such as an expanding pediatric population in developing regions, an uptick in chronic ailments affecting children, greater financial commitment to pediatric drug innovation, broader child-centric healthcare frameworks, and a heightened need for more secure pediatric treatments. Key developments anticipated in this period encompass a rising requirement for formulations suited to specific age groups, a sharper concentration on precise pediatric dosing, more frequent application of liquid and chewable medications for children, an increase in the management of chronic diseases in pediatric patients, and greater regulatory scrutiny on clinical trials involving children.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

Which Growth Drivers Are Expected To Support The Pediatric Drugs Market Forward?

An increasing incidence of preterm births is anticipated to drive expansion in the pediatric drugs market in the future. Preterm births are defined as infants delivered prior to 37 weeks of gestation, a period shorter than the usual 40-week term. This rise in preterm deliveries stems from various factors, including advanced maternal age, certain lifestyle decisions, pre-existing medical conditions, multiple gestations, and insufficient prenatal medical attention. Pediatric medications play a crucial role in supporting the health and developmental progress of preterm infants by providing specific treatments for common issues like respiratory difficulties, infections, and nutritional deficiencies. To illustrate, data from 2023, as reported by Tommy’s, a UK-based charity organization, indicated that the proportion of premature live births in England and Wales increased to 8.1%, an increment from 7.9% recorded in 2022, amounting to over 48,000 babies being born prematurely during that year. Consequently, the rising number of preterm births is a significant driver for the growth of the pediatric drugs market.

How Is The Pediatric Drugs Market Structured Across Different Market Segments?

The pediatric drugs market covered in this report is segmented –

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs

2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids

2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)

3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives

4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

What Trends Are Driving Changes In The Pediatric Drugs Market?

Leading firms in the pediatric drugs market are progressively introducing long-acting monoclonal antibodies to combat infectious diseases in infants, including RSV prevention therapies with extended half-lives. Such monoclonal antibodies are biologics formulated to persist in the bloodstream for longer periods, thus offering ongoing protection with reduced dosing frequency. As an illustration, in June 2025, Merck, a US-based pharmaceutical firm, secured FDA approval for clesrovimab (Enflonsia), a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) in infants. Clesrovimab is characterized by an extended half-life due to enhanced Fc receptor binding, provides lasting protection throughout the initial RSV season, and is administered via a single intramuscular injection.

Which Organizations Are Involved In The Pediatric Drugs Market?

Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

Access The Complete Pediatric Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

Which Region Is The Primary Market For The Pediatric Drugs Market?

North America was the largest region in the pediatric drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pediatric Drugs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

Browse Through More Reports Similar to the Global Pediatric Drugs Market 2026, By The Business Research Company

Pediatric Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-supplements-global-market-report

Pediatric Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795